Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907381 · ClinicalTrials.gov registry record
Blood Flow-restricted Resistance Exercise to Promote Muscle Strength and Use in Adults With Incomplete Spinal Cord Injury
A clinical trial, sponsored by Quality Living.
- Completed
- Registry status
- 10
- Enrollment target
NCT06907381: Completed study, sponsored by Quality Living.
NCT06907381 is a clinical trial that has completed, run by Quality Living. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06907381 has completed, sponsored by Quality Living.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Recovery of arm and hand motor control is critical for independence and quality of life following incomplete spinal cord injury (iSCI). Blood flow-restricted resistance exercise (BFRE) has emerged as a potential treatment addressing this need, but treatment guidelines and research reporting effectiveness are sparse. The purpose of this work is to provide case reports of people with cervical iSCI who use BFRE supplemented by electrical stimulation (ES) to increase the strength and functional use of selected upper extremity muscles.
Primary Outcome
Change in strength of target muscle(s) contraction as measured in pounds of force using a dynamometer.
Interventions
- BEHAVIORAL Blood flow-restricted resistance exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-06-24 |
What the finished NCT06907381 record still lists
NCT06907381 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood flow-restricted resistance exercise is the first listed.
NCT06907381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06907381 about?
NCT06907381 is a clinical study titled "Blood Flow-restricted Resistance Exercise to Promote Muscle Strength and Use in Adults With Incomplete Spinal Cord Injury". Recovery of arm and hand motor control is critical for independence and quality of life following incomplete spinal cord injury (iSCI). Blood flow-restricted resistance exercise (BFRE) has emerged as a potential treatment addressing this need, but treatment guidelines and research reporting effectiv...
What is the current status of trial NCT06907381?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2025-04-01. Estimated completion is 2026-06-24.
What interventions are being tested in trial NCT06907381?
The interventions under investigation include: Blood flow-restricted resistance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT06907381?
This trial is sponsored by Quality Living, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI